+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Burn Care Centers Market in US 2024-2028

  • PDF Icon

    Report

  • 138 Pages
  • January 2024
  • Region: United States
  • TechNavio
  • ID: 5928555
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The burn care centers market in US is forecasted to grow by USD 275.31 mn during 2023-2028, accelerating at a CAGR of 4.74% during the forecast period. The report on the burn care centers market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in rate of aging population, advances in burn care treatments, and increase in demand for cosmetic surgeries by burn patients.

The burn care centers market in US is segmented as below:

By Therapy

  • Advanced burn care
  • Biologics
  • Traditional burn care

By Type

  • Third-degree (full thickness) burns
  • Second-degree (partial thickness) burns
  • First-degree (superficial) burns

By End-user

  • Hospitals
  • Outpatient facilities
  • Home care
  • Research and manufacturing
This study identifies the increasing use of telemedicine in burn care treatments as one of the prime reasons driving the burn care centers market in US growth during the next few years. Also, new product launches and programs and conferences for medical awareness will lead to sizable demand in the market.

The report on the burn care centers market in US covers the following areas:

  • Burn care centers market in US sizing
  • Burn care centers market in US forecast
  • Burn care centers market in US industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading burn care centers market in US vendors that include Anika Therapeutics Inc., Avita Medical Inc., Burn and Reconstructive Centers of America, Coloplast AS, Grossman Burn Centers LLC, Integra Lifesciences Corp., KeraNetics Inc., Mallinckrodt Plc, MEBO Group, RenovaCare Inc., Shriners Hospitals for Children, The MetroHealth System, University of Rochester Medical Center, University of Washington, Vericel Corp., and Medline Industries LP. Also, the burn care centers market in US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Country Market Characteristics
Exhibit 04: Executive Summary - Chart on Market Segmentation by Therapy
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 08: Parent market
Exhibit 09: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 10: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 11: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 12: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 13: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 14: Chart on US: Year-over-year growth 2023-2028 (%)
Exhibit 15: Data Table on US: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Burn care centers market in US 2018 - 2022
Exhibit 16: Historic Market Size - Data Table on burn care centers market in US 2018 - 2022 ($ million)
4.2 Therapy Segment Analysis 2018 - 2022
Exhibit 17: Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
4.3 Type Segment Analysis 2018 - 2022
Exhibit 18: Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 End-user Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 20: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 23: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 24: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 25: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 26: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Therapy
6.1 Market segments
Exhibit 27: Chart on Therapy - Market share 2023-2028 (%)
Exhibit 28: Data Table on Therapy - Market share 2023-2028 (%)
6.2 Comparison by Therapy
Exhibit 29: Chart on Comparison by Therapy
Exhibit 30: Data Table on Comparison by Therapy
6.3 Advanced burn care - Market size and forecast 2023-2028
Exhibit 31: Chart on Advanced burn care - Market size and forecast 2023-2028 ($ million)
Exhibit 32: Data Table on Advanced burn care - Market size and forecast 2023-2028 ($ million)
Exhibit 33: Chart on Advanced burn care - Year-over-year growth 2023-2028 (%)
Exhibit 34: Data Table on Advanced burn care - Year-over-year growth 2023-2028 (%)
6.4 Biologics - Market size and forecast 2023-2028
Exhibit 35: Chart on Biologics - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
Exhibit 37: Chart on Biologics - Year-over-year growth 2023-2028 (%)
Exhibit 38: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
6.5 Traditional burn care - Market size and forecast 2023-2028
Exhibit 39: Chart on Traditional burn care - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Data Table on Traditional burn care - Market size and forecast 2023-2028 ($ million)
Exhibit 41: Chart on Traditional burn care - Year-over-year growth 2023-2028 (%)
Exhibit 42: Data Table on Traditional burn care - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Therapy
Exhibit 43: Market opportunity by Therapy ($ million)
Exhibit 44: Data Table on Market opportunity by Therapy ($ million)
7 Market Segmentation by Type
7.1 Market segments
Exhibit 45: Chart on Type - Market share 2023-2028 (%)
Exhibit 46: Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Exhibit 47: Chart on Comparison by Type
Exhibit 48: Data Table on Comparison by Type
7.3 Third-degree (full thickness) burns - Market size and forecast 2023-2028
Exhibit 49: Chart on Third-degree (full thickness) burns - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Data Table on Third-degree (full thickness) burns - Market size and forecast 2023-2028 ($ million)
Exhibit 51: Chart on Third-degree (full thickness) burns - Year-over-year growth 2023-2028 (%)
Exhibit 52: Data Table on Third-degree (full thickness) burns - Year-over-year growth 2023-2028 (%)
7.4 Second-degree (partial thickness) burns - Market size and forecast 2023-2028
Exhibit 53: Chart on Second-degree (partial thickness) burns - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Data Table on Second-degree (partial thickness) burns - Market size and forecast 2023-2028 ($ million)
Exhibit 55: Chart on Second-degree (partial thickness) burns - Year-over-year growth 2023-2028 (%)
Exhibit 56: Data Table on Second-degree (partial thickness) burns - Year-over-year growth 2023-2028 (%)
7.5 First-degree (superficial) burns - Market size and forecast 2023-2028
Exhibit 57: Chart on First-degree (superficial) burns - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Data Table on First-degree (superficial) burns - Market size and forecast 2023-2028 ($ million)
Exhibit 59: Chart on First-degree (superficial) burns - Year-over-year growth 2023-2028 (%)
Exhibit 60: Data Table on First-degree (superficial) burns - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Type
Exhibit 61: Market opportunity by Type ($ million)
Exhibit 62: Data Table on Market opportunity by Type ($ million)
8 Market Segmentation by End-user
8.1 Market segments
Exhibit 63: Chart on End-user - Market share 2023-2028 (%)
Exhibit 64: Data Table on End-user - Market share 2023-2028 (%)
8.2 Comparison by End-user
Exhibit 65: Chart on Comparison by End-user
Exhibit 66: Data Table on Comparison by End-user
8.3 Hospitals - Market size and forecast 2023-2028
Exhibit 67: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
8.4 Outpatient facilities - Market size and forecast 2023-2028
Exhibit 71: Chart on Outpatient facilities - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Outpatient facilities - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Outpatient facilities - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Outpatient facilities - Year-over-year growth 2023-2028 (%)
8.5 Home care - Market size and forecast 2023-2028
Exhibit 75: Chart on Home care - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Home care - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Home care - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Home care - Year-over-year growth 2023-2028 (%)
8.6 Research and manufacturing - Market size and forecast 2023-2028
Exhibit 79: Chart on Research and manufacturing - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Research and manufacturing - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Research and manufacturing - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Research and manufacturing - Year-over-year growth 2023-2028 (%)
8.7 Market opportunity by End-user
Exhibit 83: Market opportunity by End-user ($ million)
Exhibit 84: Data Table on Market opportunity by End-user ($ million)
9 Customer Landscape
9.1 Customer landscape overview
Exhibit 85: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 86: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 87: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 88: Overview on factors of disruption
11.4 Industry risks
Exhibit 89: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 90: Vendors covered
12.2 Market positioning of vendors
Exhibit 91: Matrix on vendor position and classification
12.3 Anika Therapeutics Inc.
Exhibit 92: Anika Therapeutics Inc. - Overview
Exhibit 93: Anika Therapeutics Inc. - Product / Service
Exhibit 94: Anika Therapeutics Inc. - Key offerings
12.4 Avita Medical Inc.
Exhibit 95: Avita Medical Inc. - Overview
Exhibit 96: Avita Medical Inc. - Product / Service
Exhibit 97: Avita Medical Inc. - Key offerings
12.5 Burn and Reconstructive Centers of America
Exhibit 98: Burn and Reconstructive Centers of America - Overview
Exhibit 99: Burn and Reconstructive Centers of America - Product / Service
Exhibit 100: Burn and Reconstructive Centers of America - Key offerings
12.6 Coloplast AS
Exhibit 101: Coloplast AS - Overview
Exhibit 102: Coloplast AS - Business segments
Exhibit 103: Coloplast AS - Key news
Exhibit 104: Coloplast AS - Key offerings
Exhibit 105: Coloplast AS - Segment focus
12.7 Integra Lifesciences Corp.
Exhibit 106: Integra Lifesciences Corp. - Overview
Exhibit 107: Integra Lifesciences Corp. - Business segments
Exhibit 108: Integra Lifesciences Corp. - Key news
Exhibit 109: Integra Lifesciences Corp. - Key offerings
Exhibit 110: Integra Lifesciences Corp. - Segment focus
12.8 KeraNetics Inc.
Exhibit 111: KeraNetics Inc. - Overview
Exhibit 112: KeraNetics Inc. - Product / Service
Exhibit 113: KeraNetics Inc. - Key offerings
12.9 Mallinckrodt Plc
Exhibit 114: Mallinckrodt Plc - Overview
Exhibit 115: Mallinckrodt Plc - Business segments
Exhibit 116: Mallinckrodt Plc - Key offerings
Exhibit 117: Mallinckrodt Plc - Segment focus
12.10 MEBO Group
Exhibit 118: MEBO Group - Overview
Exhibit 119: MEBO Group - Product / Service
Exhibit 120: MEBO Group - Key offerings
12.11 Medline Industries LP
Exhibit 121: Medline Industries LP - Overview
Exhibit 122: Medline Industries LP - Product / Service
Exhibit 123: Medline Industries LP - Key offerings
12.12 RenovaCare Inc.
Exhibit 124: RenovaCare Inc. - Overview
Exhibit 125: RenovaCare Inc. - Product / Service
Exhibit 126: RenovaCare Inc. - Key offerings
12.13 Shriners Hospitals for Children
Exhibit 127: Shriners Hospitals for Children - Overview
Exhibit 128: Shriners Hospitals for Children - Product / Service
Exhibit 129: Shriners Hospitals for Children - Key offerings
12.14 The MetroHealth System
Exhibit 130: The MetroHealth System - Overview
Exhibit 131: The MetroHealth System - Product / Service
Exhibit 132: The MetroHealth System - Key offerings
12.15 University of Rochester Medical Center
Exhibit 133: University of Rochester Medical Center - Overview
Exhibit 134: University of Rochester Medical Center - Product / Service
Exhibit 135: University of Rochester Medical Center - Key offerings
12.16 University of Washington
Exhibit 136: University of Washington - Overview
Exhibit 137: University of Washington - Product / Service
Exhibit 138: University of Washington - Key offerings
12.17 Vericel Corp.
Exhibit 139: Vericel Corp. - Overview
Exhibit 140: Vericel Corp. - Product / Service
Exhibit 141: Vericel Corp. - Key news
Exhibit 142: Vericel Corp. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 143: Inclusions checklist
Exhibit 144: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 145: Currency conversion rates for US$
13.4 Research methodology
Exhibit 146: Research methodology
Exhibit 147: Validation techniques employed for market sizing
Exhibit 148: Information sources
13.5 List of abbreviations
Exhibit 149: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Country Market Characteristics
Exhibits 4: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Vendor Market Positioning
Exhibits 8: Parent market
Exhibits 9: Market Characteristics
Exhibits 10: Offerings of vendors included in the market definition
Exhibits 11: Market segments
Exhibits 12: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 13: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 14: Chart on US: Year-over-year growth 2023-2028 (%)
Exhibits 15: Data Table on US: Year-over-year growth 2023-2028 (%)
Exhibits 16: Historic Market Size - Data Table on burn care centers market in US 2018 - 2022 ($ million)
Exhibits 17: Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
Exhibits 18: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits 20: Five forces analysis - Comparison between 2023 and 2028
Exhibits 21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 23: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 24: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 25: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 26: Chart on Market condition - Five forces 2023 and 2028
Exhibits 27: Chart on Therapy - Market share 2023-2028 (%)
Exhibits 28: Data Table on Therapy - Market share 2023-2028 (%)
Exhibits 29: Chart on Comparison by Therapy
Exhibits 30: Data Table on Comparison by Therapy
Exhibits 31: Chart on Advanced burn care - Market size and forecast 2023-2028 ($ million)
Exhibits 32: Data Table on Advanced burn care - Market size and forecast 2023-2028 ($ million)
Exhibits 33: Chart on Advanced burn care - Year-over-year growth 2023-2028 (%)
Exhibits 34: Data Table on Advanced burn care - Year-over-year growth 2023-2028 (%)
Exhibits 35: Chart on Biologics - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Chart on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits 38: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits 39: Chart on Traditional burn care - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Data Table on Traditional burn care - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Chart on Traditional burn care - Year-over-year growth 2023-2028 (%)
Exhibits 42: Data Table on Traditional burn care - Year-over-year growth 2023-2028 (%)
Exhibits 43: Market opportunity by Therapy ($ million)
Exhibits 44: Data Table on Market opportunity by Therapy ($ million)
Exhibits 45: Chart on Type - Market share 2023-2028 (%)
Exhibits 46: Data Table on Type - Market share 2023-2028 (%)
Exhibits 47: Chart on Comparison by Type
Exhibits 48: Data Table on Comparison by Type
Exhibits 49: Chart on Third-degree (full thickness) burns - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Data Table on Third-degree (full thickness) burns - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Chart on Third-degree (full thickness) burns - Year-over-year growth 2023-2028 (%)
Exhibits 52: Data Table on Third-degree (full thickness) burns - Year-over-year growth 2023-2028 (%)
Exhibits 53: Chart on Second-degree (partial thickness) burns - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on Second-degree (partial thickness) burns - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on Second-degree (partial thickness) burns - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on Second-degree (partial thickness) burns - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on First-degree (superficial) burns - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on First-degree (superficial) burns - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on First-degree (superficial) burns - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on First-degree (superficial) burns - Year-over-year growth 2023-2028 (%)
Exhibits 61: Market opportunity by Type ($ million)
Exhibits 62: Data Table on Market opportunity by Type ($ million)
Exhibits 63: Chart on End-user - Market share 2023-2028 (%)
Exhibits 64: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 65: Chart on Comparison by End-user
Exhibits 66: Data Table on Comparison by End-user
Exhibits 67: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits 68: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits 69: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 70: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 71: Chart on Outpatient facilities - Market size and forecast 2023-2028 ($ million)
Exhibits 72: Data Table on Outpatient facilities - Market size and forecast 2023-2028 ($ million)
Exhibits 73: Chart on Outpatient facilities - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on Outpatient facilities - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Home care - Market size and forecast 2023-2028 ($ million)
Exhibits 76: Data Table on Home care - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Chart on Home care - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Home care - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Research and manufacturing - Market size and forecast 2023-2028 ($ million)
Exhibits 80: Data Table on Research and manufacturing - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Chart on Research and manufacturing - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Research and manufacturing - Year-over-year growth 2023-2028 (%)
Exhibits 83: Market opportunity by End-user ($ million)
Exhibits 84: Data Table on Market opportunity by End-user ($ million)
Exhibits 85: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 86: Impact of drivers and challenges in 2023 and 2028
Exhibits 87: Overview on Criticality of inputs and Factors of differentiation
Exhibits 88: Overview on factors of disruption
Exhibits 89: Impact of key risks on business
Exhibits 90: Vendors covered
Exhibits 91: Matrix on vendor position and classification
Exhibits 92: Anika Therapeutics Inc. - Overview
Exhibits 93: Anika Therapeutics Inc. - Product / Service
Exhibits 94: Anika Therapeutics Inc. - Key offerings
Exhibits 95: Avita Medical Inc. - Overview
Exhibits 96: Avita Medical Inc. - Product / Service
Exhibits 97: Avita Medical Inc. - Key offerings
Exhibits 98: Burn and Reconstructive Centers of America - Overview
Exhibits 99: Burn and Reconstructive Centers of America - Product / Service
Exhibits 100: Burn and Reconstructive Centers of America - Key offerings
Exhibits 101: Coloplast AS - Overview
Exhibits 102: Coloplast AS - Business segments
Exhibits 103: Coloplast AS - Key news
Exhibits 104: Coloplast AS - Key offerings
Exhibits 105: Coloplast AS - Segment focus
Exhibits 106: Integra Lifesciences Corp. - Overview
Exhibits 107: Integra Lifesciences Corp. - Business segments
Exhibits 108: Integra Lifesciences Corp. - Key news
Exhibits 109: Integra Lifesciences Corp. - Key offerings
Exhibits 110: Integra Lifesciences Corp. - Segment focus
Exhibits 111: KeraNetics Inc. - Overview
Exhibits 112: KeraNetics Inc. - Product / Service
Exhibits 113: KeraNetics Inc. - Key offerings
Exhibits 114: Mallinckrodt Plc - Overview
Exhibits 115: Mallinckrodt Plc - Business segments
Exhibits 116: Mallinckrodt Plc - Key offerings
Exhibits 117: Mallinckrodt Plc - Segment focus
Exhibits 118: MEBO Group - Overview
Exhibits 119: MEBO Group - Product / Service
Exhibits 120: MEBO Group - Key offerings
Exhibits 121: Medline Industries LP - Overview
Exhibits 122: Medline Industries LP - Product / Service
Exhibits 123: Medline Industries LP - Key offerings
Exhibits 124: RenovaCare Inc. - Overview
Exhibits 125: RenovaCare Inc. - Product / Service
Exhibits 126: RenovaCare Inc. - Key offerings
Exhibits 127: Shriners Hospitals for Children - Overview
Exhibits 128: Shriners Hospitals for Children - Product / Service
Exhibits 129: Shriners Hospitals for Children - Key offerings
Exhibits 130: The MetroHealth System - Overview
Exhibits 131: The MetroHealth System - Product / Service
Exhibits 132: The MetroHealth System - Key offerings
Exhibits 133: University of Rochester Medical Center - Overview
Exhibits 134: University of Rochester Medical Center - Product / Service
Exhibits 135: University of Rochester Medical Center - Key offerings
Exhibits 136: University of Washington - Overview
Exhibits 137: University of Washington - Product / Service
Exhibits 138: University of Washington - Key offerings
Exhibits 139: Vericel Corp. - Overview
Exhibits 140: Vericel Corp. - Product / Service
Exhibits 141: Vericel Corp. - Key news
Exhibits 142: Vericel Corp. - Key offerings
Exhibits 143: Inclusions checklist
Exhibits 144: Exclusions checklist
Exhibits 145: Currency conversion rates for US$
Exhibits 146: Research methodology
Exhibits 147: Validation techniques employed for market sizing
Exhibits 148: Information sources
Exhibits 149: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the burn care centers market in US: Anika Therapeutics Inc., Avita Medical Inc., Burn and Reconstructive Centers of America, Coloplast AS, Grossman Burn Centers LLC, Integra Lifesciences Corp., KeraNetics Inc., Mallinckrodt Plc, MEBO Group, RenovaCare Inc., Shriners Hospitals for Children, The MetroHealth System, University of Rochester Medical Center, University of Washington, Vericel Corp., and Medline Industries LP.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing use of telemedicine in burn care treatments.'

According to the report, one of the major drivers for this market is the increase in rate of aging population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Anika Therapeutics Inc.
  • Avita Medical Inc.
  • Burn and Reconstructive Centers of America
  • Coloplast AS
  • Grossman Burn Centers LLC
  • Integra Lifesciences Corp.
  • KeraNetics Inc.
  • Mallinckrodt Plc
  • MEBO Group
  • RenovaCare Inc.
  • Shriners Hospitals for Children
  • The MetroHealth System
  • University of Rochester Medical Center
  • University of Washington
  • Vericel Corp.
  • Medline Industries LP